Literature DB >> 20703228

Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study.

Atsuhiro Kanno1, Hirohito Metoki, Masahiro Kikuya, Hiroyuki Terawaki, Azusa Hara, Takanao Hashimoto, Kei Asayama, Ryusuke Inoue, Yoh Shishido, Masaaki Nakayama, Kazuhito Totsune, Takayoshi Ohkubo, Yutaka Imai.   

Abstract

Masked hypertension (MHT) is considered to be associated with organ damage, whereas the association of white-coat hypertension (WCHT) with organ damage remains controversial. Using home blood pressure measurements, we have previously reported that MHT is associated with a risk of chronic kidney disease (CKD) compared with sustained normal blood pressure (SNBP), although WCHT was not significantly related to CKD in a general Japanese population. The objective of this study was to examine CKD risk associated with WCHT and MHT as determined by ambulatory blood pressure (ABP) monitoring. Among 1023 residents in the general Japanese population of Ohasama, ABP and casual blood pressure (CBP) levels were recorded and blood and urine samples were collected. CKD was defined as a positive proteinuria and/or estimated glomerular filtration rate <60 ml min⁻¹ per 1.73 m². Participants were categorized into four groups using daytime ABP of 140/85 mm Hg and CBP of 140/90 mm Hg as cutoff points: SNBP, 60.0%; WCHT, 15.4%; MHT, 15.0%; and sustained hypertension (SHT), 9.6%. Odds ratios (ORs) for prevalence of CKD were calculated using a multiple logistic regression model. Compared with SNBP, risk of CKD was significantly higher in SHT (OR, 2.81; 95% confidence interval (CI), 1.66-4.75; P=0.0001), MHT (OR, 2.29; 95% CI, 1.45-3.63; P=0.0004) and WCHT (OR, 1.67; 95% CI, 1.03-2.71; P=0.0368). CKD was significantly associated with MHT and WCHT on the basis of ABP monitoring compared with SNBP in the general Japanese population.

Entities:  

Mesh:

Year:  2010        PMID: 20703228     DOI: 10.1038/hr.2010.139

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  12 in total

1.  Blood pressure phenotype reproducibility in CKD outpatients: a clinical practice report.

Authors:  Adamasco Cupisti; R M Bruno; A Puntoni; E Varricchio; E Giglio; O Meniconi; C Zullo; M Barsotti; M F Egidi; L Ghiadoni
Journal:  Intern Emerg Med       Date:  2019-06-17       Impact factor: 3.397

2.  White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study.

Authors:  Jun Hata; Masayo Fukuhara; Satoko Sakata; Hisatomi Arima; Yoichiro Hirakawa; Koji Yonemoto; Naoko Mukai; Takanari Kitazono; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  Hypertens Res       Date:  2017-09-07       Impact factor: 3.872

3.  Clinical correlates of ambulatory BP monitoring among patients with CKD.

Authors:  Satoshi Iimuro; Enyu Imai; Tsuyoshi Watanabe; Kosaku Nitta; Tadao Akizawa; Seiichi Matsuo; Hirofumi Makino; Yasuo Ohashi; Akira Hishida
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

Review 4.  Blood pressure measurement: clinic, home, ambulatory, and beyond.

Authors:  Paul E Drawz; Mohamed Abdalla; Mahboob Rahman
Journal:  Am J Kidney Dis       Date:  2012-04-21       Impact factor: 8.860

Review 5.  Ambulatory blood pressure in chronic kidney disease.

Authors:  Debbie L Cohen; Yonghong Huan; Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 6.  Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension.

Authors:  Jordana B Cohen; Debbie L Cohen
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

7.  Masked hypertension and kidney function decline: the Jackson Heart Study.

Authors:  Stanford Mwasongwe; Yuan-I Min; John N Booth; Ronit Katz; Mario Sims; Adolfo Correa; Bessie Young; Paul Muntner
Journal:  J Hypertens       Date:  2018-07       Impact factor: 4.844

Review 8.  Treatment of Hypertension in Chronic Kidney Disease.

Authors:  Rigas G Kalaitzidis; Moses S Elisaf
Journal:  Curr Hypertens Rep       Date:  2018-06-11       Impact factor: 5.369

9.  Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C.

Authors:  Emmanuel Androulakis; Nikolaos Papageorgiou; Eirini Lioudaki; Evaggelos Chatzistamatiou; Effimia Zacharia; Ioannis Kallikazaros; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-21       Impact factor: 3.738

10.  Utility of 24-hour ambulatory blood pressure monitoring in potential living kidney donors.

Authors:  Nabeel Aslam; Sobia H Memon; Hani Wadei; Elizabeth R Lesser; Shehzad K Niazi
Journal:  Clin Hypertens       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.